These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12098071)

  • 1. Incidence of cytomegalovirus (CMV) infection in allogeneic hematopoietic stem cell recipients at low risk of CMV infection.
    Mori T; Okamoto S; Watanabe R; Yamazaki R; Tsukada Y; Nagayama H; Ishida A; Ikeda Y
    Bone Marrow Transplant; 2002 Jun; 29(12):1005-6. PubMed ID: 12098071
    [No Abstract]   [Full Text] [Related]  

  • 2. Surveillance of cytomegalovirus (CMV) DNAemia in pediatric allogeneic stem cell transplantation: incidence and outcome of CMV infection and disease.
    Bordon V; Bravo S; Van Renterghem L; de Moerloose B; Benoit Y; Laureys G; Dhooge C
    Transpl Infect Dis; 2008 Feb; 10(1):19-23. PubMed ID: 17511814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation (Allo-HSCT) and related risk factors].
    Huang XJ; Xu LP; Ren HY; Zhang YC; Guo NL; Lu DP
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):766-9. PubMed ID: 12899755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors for persistent cytomegalovirus reactivation after T-cell-depleted allogeneic hematopoietic stem cell transplantation.
    Almyroudis NG; Jakubowski A; Jaffe D; Sepkowitz K; Pamer E; O'Reilly RJ; Papanicolaou GA
    Transpl Infect Dis; 2007 Dec; 9(4):286-94. PubMed ID: 17511819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DRB1*09 is associated with increased incidence of cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation.
    Du J; Liu J; Gu J; Zhu P
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1417-21. PubMed ID: 18022570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus infection after allogeneic transplantation: comparison of cord blood with peripheral blood and marrow graft sources.
    Walker CM; van Burik JA; De For TE; Weisdorf DJ
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1106-15. PubMed ID: 17697973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for late cytomegalovirus infection after allogeneic stem cell transplantation using HLA-matched sibling donor: donor lymphocyte infusion and previous history of early CMV infection.
    Kim DH; Kim JG; Lee NY; Sung WJ; Sohn SK; Suh JS; Lee KS; Lee KB
    Bone Marrow Transplant; 2004 Jul; 34(1):21-7. PubMed ID: 15133483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized clinical trial of ganciclovir vs acyclovir for prevention of cytomegalovirus antigenemia after allogeneic transplantation.
    Burns LJ; Miller W; Kandaswamy C; DeFor TE; MacMillan ML; Van Burik JA; Weisdorf DJ
    Bone Marrow Transplant; 2002 Dec; 30(12):945-51. PubMed ID: 12476289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infections after allogeneic hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimen.
    Frère P; Baron F; Bonnet C; Hafraoui K; Pereira M; Willems E; Fillet G; Beguin Y
    Bone Marrow Transplant; 2006 Feb; 37(4):411-8. PubMed ID: 16415900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantation.
    Ljungman P; Perez-Bercoff L; Jonsson J; Avetisyan G; Sparrelid E; Aschan J; Barkholt L; Larsson K; Winiarski J; Yun Z; Ringdén O
    Haematologica; 2006 Jan; 91(1):78-83. PubMed ID: 16434374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus enteritis among hematopoietic stem cell transplant recipients.
    van Burik JA; Lawatsch EJ; DeFor TE; Weisdorf DJ
    Biol Blood Marrow Transplant; 2001; 7(12):674-9. PubMed ID: 11787530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of cytomegalovirus infection by polymerase chain reaction in hematopoietic stem cell transplantation recipients].
    Xu LP; Huang XJ; Guo NL; Ren HY; Zhang YC; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2003 Aug; 24(8):407-9. PubMed ID: 14642176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the NucliSens CMV pp67 assay for detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation.
    Hebart H; Rudolph T; Loeffler J; Middeldorp J; Ljubicic T; Jahn G; Einsele H
    Bone Marrow Transplant; 2002 Aug; 30(3):181-7. PubMed ID: 12189537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-grade cytomegalovirus antigenemia after hematopoietic stem cell transplantation.
    Asano-Mori Y; Oshima K; Sakata-Yanagimoto M; Nakagawa M; Kandabashi K; Izutsu K; Hangaishi A; Motokura T; Chiba S; Kurokawa M; Hirai H; Kanda Y
    Bone Marrow Transplant; 2005 Nov; 36(9):813-9. PubMed ID: 16151428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus infection after allogeneic stem cell transplant in children.
    Haastrup E; Müller K; Baekgaard H; Heilmann C
    Pediatr Transplant; 2005 Dec; 9(6):734-40. PubMed ID: 16269044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus-host disease.
    van Burik JA; Carter SL; Freifeld AG; High KP; Godder KT; Papanicolaou GA; Mendizabal AM; Wagner JE; Yanovich S; Kernan NA
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1487-98. PubMed ID: 18022579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus (CMV) infections in children undergoing hematopoetic stem cell transplantation.
    Zaucha-Prazmo A; Wójcik B; Drabko K; Choma M; Kowalczyk JR
    Pediatr Hematol Oncol; 2005 Jun; 22(4):271-6. PubMed ID: 16020113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevention and treatment of cytomegalovirus infection in haematopoietic stem cell transplantation.
    Tuthill M; Chen F; Paston S; De La Peña H; Rusakiewicz S; Madrigal A
    Cancer Immunol Immunother; 2009 Sep; 58(9):1481-8. PubMed ID: 19466407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after allogeneic hematopoietic stem cell transplantation.
    Mori T; Mori S; Kanda Y; Yakushiji K; Mineishi S; Takaue Y; Gondo H; Harada M; Sakamaki H; Yajima T; Iwao Y; Hibi T; Okamoto S
    Bone Marrow Transplant; 2004 Feb; 33(4):431-4. PubMed ID: 14676775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regimen-related mucosal injury of the gut increased the incidence of CMV disease after allogeneic bone marrow transplantation.
    Shigematsu A; Yasumoto A; Yamamoto S; Sugita J; Kondo T; Onozawa M; Kahata K; Endo T; Ota S; Sato N; Takahata M; Okada K; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):679-85. PubMed ID: 19450752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.